These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 32429195)

  • 41. T Lymphocyte Dynamics in Inflammatory Bowel Diseases: Role of the Microbiome.
    Larmonier CB; Shehab KW; Ghishan FK; Kiela PR
    Biomed Res Int; 2015; 2015():504638. PubMed ID: 26583115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
    Robinson AM; Gondalia SV; Karpe AV; Eri R; Beale DJ; Morrison PD; Palombo EA; Nurgali K
    Inflamm Bowel Dis; 2016 Dec; 22(12):2767-2787. PubMed ID: 27824648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.
    Lavelle A; Sokol H
    Nat Rev Gastroenterol Hepatol; 2020 Apr; 17(4):223-237. PubMed ID: 32076145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The microbiome of translocated bacterial populations in patients with and without inflammatory bowel disease.
    Kiely CJ; Pavli P; O'Brien CL
    Intern Med J; 2018 Nov; 48(11):1346-1354. PubMed ID: 29893034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunometabolism and microbial metabolites at the gut barrier: Lessons for therapeutic intervention in inflammatory bowel disease.
    Michaels M; Madsen KL
    Mucosal Immunol; 2023 Feb; 16(1):72-85. PubMed ID: 36642380
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolite-Sensing G Protein-Coupled Receptors Connect the Diet-Microbiota-Metabolites Axis to Inflammatory Bowel Disease.
    Melhem H; Kaya B; Ayata CK; Hruz P; Niess JH
    Cells; 2019 May; 8(5):. PubMed ID: 31091682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New insights into the interplay between autophagy, gut microbiota and insulin resistance in metabolic syndrome.
    Zhao J; Duan L; Li J; Yao C; Wang G; Mi J; Yu Y; Ding L; Zhao Y; Yan G; Li J; Zhao Z; Wang X; Li M
    Biomed Pharmacother; 2024 Jul; 176():116807. PubMed ID: 38795644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frontline defenders: goblet cell mediators dictate host-microbe interactions in the intestinal tract during health and disease.
    Allaire JM; Morampudi V; Crowley SM; Stahl M; Yu H; Bhullar K; Knodler LA; Bressler B; Jacobson K; Vallance BA
    Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G360-G377. PubMed ID: 29122749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The human gut microbiota].
    Knudsen JK; Bundgaard-Nielsen C; Hagstrøm S; Sørensen S; Leutscher P
    Ugeskr Laeger; 2017 Dec; 179(49):. PubMed ID: 29212595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis.
    He Y; Wu W; Wu S; Zheng HM; Li P; Sheng HF; Chen MX; Chen ZH; Ji GY; Zheng ZD; Mujagond P; Chen XJ; Rong ZH; Chen P; Lyu LY; Wang X; Xu JB; Wu CB; Yu N; Xu YJ; Yin J; Raes J; Ma WJ; Zhou HW
    Microbiome; 2018 Sep; 6(1):172. PubMed ID: 30249275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deep in the Bowel: Highly Interpretable Neural Encoder-Decoder Networks Predict Gut Metabolites from Gut Microbiome.
    Le V; Quinn TP; Tran T; Venkatesh S
    BMC Genomics; 2020 Jul; 21(Suppl 4):256. PubMed ID: 32689932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polybrominated Diphenyl Ethers and Gut Microbiome Modulate Metabolic Syndrome-Related Aqueous Metabolites in Mice.
    Scoville DK; Li CY; Wang D; Dempsey JL; Raftery D; Mani S; Gu H; Cui JY
    Drug Metab Dispos; 2019 Aug; 47(8):928-940. PubMed ID: 31123037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inflammatory Bowel Diseases: The Role of Gut Microbiota.
    De Musis C; Granata L; Dallio M; Miranda A; Gravina AG; Romano M
    Curr Pharm Des; 2020; 26(25):2951-2961. PubMed ID: 32310042
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The interplay between microbes and the immune response in inflammatory bowel disease.
    Goethel A; Croitoru K; Philpott DJ
    J Physiol; 2018 Sep; 596(17):3869-3882. PubMed ID: 29806140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dietary Implications of the Bidirectional Relationship between the Gut Microflora and Inflammatory Diseases with Special Emphasis on Irritable Bowel Disease: Current and Future Perspective.
    Aziz T; Khan AA; Tzora A; Voidarou CC; Skoufos I
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.